Risk of osteoporotic fractures in new users of denosumab compared with new users of alendronate: A Danish populationbased cohort study

Documents similaires

• Comparison of risk of osteoporotic fracture in Denosumab vs Alendronate treatment within 3 years of initiation
  par: Pedersen, AB, et autres
  Publié: (2019)
• The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
  par: Rikke Viggers, et autres
  Publié: (2022-01-01)
• Danish clinical quality databases – an important and untapped resource for clinical research
  par: Sørensen HT, et autres
  Publié: (2016-10-01)
• Denosumab for the prevention of osteoporotic fractures in postmenopausal women
  par: N Waugh, et autres
  Publié: (2011-05-01)
• Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
  par: Eiken, P, et autres
  Publié: (2017)